A nationwide survey of neonatologists and pediatric neurologists was conducted to ascertain their methods of evaluating and managing neonatal seizures. Of the sampled 750 physicians, 284 (38%) responded to the single mailing. Most respondents use a routine for seizure workup which includes glucose, calcium and electrolyte determinations, and a lumbar puncture. On the other hand, there was a great variation in the use of an EEG, CT scan, skull x-ray, and a drug and metabolic screen.
Phenobarbital was the initial drug of choice and phenytoin usually the second drug. Neurologists used higher loading doses for phenobarbital and phenytoin. Most physicians monitored blood levels to adjust maintenance doses. Drug therapy was usually continued for two months to one year after seizure control. Criteria for discontinuation were often arbitrary but included a normal electroencephalogram and the absence of seizures. The results demonstrate a lack of consensus in the evaluation and management of neonates with seizures.
Get full access to this article
View all access options for this article.
References
1.
Fenichel GMNeonatal neurology. New York: Churchill Livingstone, 1980:20-44.
2.
Seay AR, Bray PFSignificance of seizures in infants less than 2500 grams. Arch Neurol1977;34:381.
3.
Kendall SRDiagnosis and treatment of neonatal seizures. Drug Ther1977;7:7.
4.
Freeman JM, Brann AWCentral nervous system disturbances. In Behrman RE, ed. Neonatal-perinatal medicine. 2nd ed. St. Louis: CV Mosby, 1977:787-836.
5.
Volpe JJ, Koenigsberger R.Neurologic disorders. In Avery GB, ed. Neonatology, pathophysiology and management of the newborn. Philadelphia: JB Lippincott, 1981 :910-63.
6.
Meyer CL, Schreiner RLSeizures. In Schreiner RL, ed. Care of the newborn. New York: Raven Press, 1982:196-202.
7.
Painter MJ, Pippenger C., McDonald H., et al. Phenobarbital and diphenylhydantoin levels in neonates with seizures. J Pediatr1978;91:315.
8.
Gal P., Toback J., Erkan NV, et al. Phenobarbital levels for neonatal seizures. Presented at the 15th Annual ASHP Midyear Clinical Meeting, San Francisco, California, December 1980.
9.
Lockman LA, Kriel R., Zaske D., et al. Phenobarbital dosage for control of neonatal seizures. Neurology1979;29:1445.
10.
Schain RI, Watanabe K.Effect of chronic phenobarbital administration upon brain growth of the infant . Exp Neurol1975;47:709.
11.
Diaz J., Schain RJ, Bailey BGPhenobarbital-induced brain growth retardation in artificially reared rat pups. Biol Neonate1977;32:77.
12.
Camfield CS , Chaplin S., Doyle A., et al. Side effects of phenobarbital in toddlers; behavioral and cognitive aspects. J Pediatr1979;95-361.
13.
Ellison PH, Largent JA, Bahr JPA scoring system to predict outcome following neonatal seizures. J Pediatr1981;99:455.
14.
Gal P., Boer HREarly discontinuation of anticonvulsants following neonatal seizures: a preliminary report. South Med J1982;75:298.
